# Alan G. Jardine

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/alan-g-jardine/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,053 |
| Field | Renal Transplantation Outcomes and Treatments |
| h-index | 73 |
| i10-index | 227 |
| Last Known Institution | British Heart Foundation |
| OpenAlex ID | https://openalex.org/A5071642919 |
| ORCID iD | https://orcid.org/0000-0001-5815-9370 |
| Works | 433 |

## Researcher papers

- [Rosuvastatin and Cardiovascular Events in Patients Undergoing Hemodialysis](https://scholariq.org/papers/rosuvastatin-and-cardiovascular-events-in-patients-undergoing-hemodialysis/)
- [Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials](https://scholariq.org/papers/efficacy-and-safety-of-statin-therapy-in-older-people-a-meta-analysis-of/)
- [Chronic Kidney Disease and Coronary Artery Disease](https://scholariq.org/papers/chronic-kidney-disease-and-coronary-artery-disease/)
- [Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions](https://scholariq.org/papers/proceedings-from-an-international-consensus-meeting-on-posttransplantation/)
- [Targeted-release budesonide versus placebo in patients with IgA nephropathy (NEFIGAN): a double-blind, randomised, placebo-controlled phase 2b trial](https://scholariq.org/papers/targeted-release-budesonide-versus-placebo-in-patients-with-iga-nephropathy/)
- [Gadolinium-enhanced MR Imaging and Nephrogenic Systemic Fibrosis: Retrospective Study of a Renal Replacement Therapy Cohort](https://scholariq.org/papers/gadolinium-enhanced-mr-imaging-and-nephrogenic-systemic-fibrosis-retrospective/)
- [Practical Recommendations for Long-term Management of Modifiable Risks in Kidney and Liver Transplant Recipients](https://scholariq.org/papers/practical-recommendations-for-long-term-management-of-modifiable-risks-in-kidney/)
- [Chronic kidney disease and arrhythmias: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/chronic-kidney-disease-and-arrhythmias-conclusions-from-a-kidney-disease/)
- [Vadadustat in Patients with Anemia and Non–Dialysis-Dependent CKD](https://scholariq.org/papers/vadadustat-in-patients-with-anemia-and-non-dialysis-dependent-ckd/)
- [Polymorphisms in angiotensin-converting-enzyme gene and progression of IgA nephropathy](https://scholariq.org/papers/polymorphisms-in-angiotensin-converting-enzyme-gene-and-progression-of-iga/)
- [Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis](https://scholariq.org/papers/effect-of-mineralocorticoid-receptor-antagonists-on-proteinuria-and-progression/)
- [Chronic kidney disease and valvular heart disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/chronic-kidney-disease-and-valvular-heart-disease-conclusions-from-a-kidney/)

## Researcher topics

- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Transplantation: Methods and Outcomes](https://scholariq.org/topics/transplantation-methods-and-outcomes-2/)
- [Lipoproteins and Cardiovascular Health](https://scholariq.org/topics/lipoproteins-and-cardiovascular-health/)

## Researcher university

- [British Heart Foundation](https://scholariq.org/institutions/british-heart-foundation/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.
